[go: up one dir, main page]

DD259191A1 - Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten - Google Patents

Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten Download PDF

Info

Publication number
DD259191A1
DD259191A1 DD85283042A DD28304285A DD259191A1 DD 259191 A1 DD259191 A1 DD 259191A1 DD 85283042 A DD85283042 A DD 85283042A DD 28304285 A DD28304285 A DD 28304285A DD 259191 A1 DD259191 A1 DD 259191A1
Authority
DD
German Democratic Republic
Prior art keywords
aik
silibinin
independently
derivatives
carbon atoms
Prior art date
Application number
DD85283042A
Other languages
German (de)
English (en)
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of DD259191A1 publication Critical patent/DD259191A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
DD85283042A 1984-11-22 1985-11-20 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten DD259191A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
DD259191A1 true DD259191A1 (de) 1988-08-17

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85283042A DD259191A1 (de) 1984-11-22 1985-11-20 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Country Status (29)

Country Link
JP (1) JPS61143377A (xx)
KR (1) KR870001020B1 (xx)
AR (1) AR240931A1 (xx)
AT (1) AT393268B (xx)
BE (1) BE903693A (xx)
CA (1) CA1337124C (xx)
CH (1) CH659473A5 (xx)
CS (1) CS273610B2 (xx)
DD (1) DD259191A1 (xx)
DE (1) DE3442639A1 (xx)
DK (1) DK164865C (xx)
EG (1) EG19424A (xx)
ES (1) ES8609311A1 (xx)
FI (1) FI84064C (xx)
FR (1) FR2573427B1 (xx)
GB (1) GB2167414B (xx)
HU (1) HU195503B (xx)
IE (1) IE58791B1 (xx)
IT (1) IT1190426B (xx)
LU (1) LU86163A1 (xx)
MX (1) MX168415B (xx)
NL (1) NL192387C (xx)
NO (1) NO160205C (xx)
PL (1) PL146890B1 (xx)
PT (1) PT81532B (xx)
SE (1) SE465676B (xx)
SU (1) SU1436875A3 (xx)
YU (1) YU43689B (xx)
ZA (1) ZA858951B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
DK1856085T3 (en) * 2005-03-11 2015-10-05 Howard Florey Inst Pty Ltd FLAVONOID COMPOUNDS AND APPLICATIONS THEREOF
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
WO2009062737A1 (en) * 2007-11-15 2009-05-22 Madaus Gmbh Silibinin component for the treatment of hepatitis
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
US20150174213A1 (en) 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
GB8528226D0 (en) 1985-12-18
JPS61143377A (ja) 1986-07-01
FI854535A0 (fi) 1985-11-18
FR2573427A1 (fr) 1986-05-23
ES549116A0 (es) 1986-09-01
HU195503B (en) 1988-05-30
BE903693A (fr) 1986-05-22
YU43689B (en) 1989-10-31
NO160205B (no) 1988-12-12
SE8505487D0 (sv) 1985-11-20
CA1337124C (en) 1995-09-26
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
FI84064C (fi) 1991-10-10
DE3442639C2 (xx) 1989-08-10
AR240931A1 (es) 1991-03-27
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
YU178685A (en) 1988-02-29
DK164865B (da) 1992-08-31
FI84064B (fi) 1991-06-28
ES8609311A1 (es) 1986-09-01
AR240931A2 (es) 1991-03-27
LU86163A1 (de) 1986-03-24
GB2167414A (en) 1986-05-29
EG19424A (en) 1995-02-28
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
JPH0432073B2 (xx) 1992-05-28
IT1190426B (it) 1988-02-16
SU1436875A3 (ru) 1988-11-07
NL8503171A (nl) 1986-06-16
KR860004056A (ko) 1986-06-16
ZA858951B (en) 1986-08-27
DK537785A (da) 1986-05-23
NL192387B (nl) 1997-03-03
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
CH659473A5 (de) 1987-01-30
SE8505487L (sv) 1986-05-23
AT393268B (de) 1991-09-25
KR870001020B1 (ko) 1987-05-23
PT81532B (pt) 1987-11-11
ATA337185A (de) 1991-02-15
IE58791B1 (en) 1993-11-17
NO854655L (no) 1986-05-23
IT8522932A0 (it) 1985-11-21
NL192387C (nl) 1997-07-04
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
MX168415B (es) 1993-05-24
PL256374A1 (en) 1986-12-02
GB2167414B (en) 1989-01-11
FI854535A (fi) 1986-05-23
NO160205C (no) 1989-03-22
IE852808L (en) 1986-05-22

Similar Documents

Publication Publication Date Title
EP0013983B1 (de) Antineoplastische Mittel auf Basis von nicht oder nur geringfügig irritierenden und/oder promovierenden Diterpenalkoholen und Derivaten davon und deren Herstellung
DE69007035T2 (de) Extrakt von Ginkgo biloba-Blättern, sein Verfahren zur Herstellung und Arzneimittel, die es enthalten.
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
EP0501205B1 (de) Antiphlogistisches Mittel
WO1987003480A2 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
DE3537656C2 (xx)
EP0472501B1 (de) Codeinsalz einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE4013696A1 (de) Salze des azelastins mit verbesserter loeslichkeit
DE3442639C2 (xx)
DE3511609C2 (xx)
DE69105767T2 (de) Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese.
DE3784595T2 (de) Arzneimittel gegen feste tumoren.
DE2241742C3 (de) Verwendung von Hydroxyprolinderivaten bei der äußerlichen Behandlung von Bindegewebserkrankungen
DE69019517T2 (de) Neolignanderivatkomplexen mit Phospolipiden, deren Verwendung und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen.
DE102004063910B4 (de) Trisubstituierte Benzopyranone sowie diese enthaltende Pflanzenextrakte und Mittel
EP0505519B1 (de) Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung
DE2632118B2 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
EP0664131A1 (de) Optimal freisetzende Kava-Extrakte
DE2729903A1 (de) Antithrombosemittel
DE3544457A1 (de) Arzneimittel zur behandlung von leberkrankheiten
DE2515142B2 (de) Oral verabfolgbare mittel zur senkung des lipid- und cholesterin- spiegels
DE60124315T2 (de) Eine aus der pflanze humboldtia decurrens gewonnene antidiabetische verbindung und ein verfahren zu ihrer herstellung
DD258231A1 (de) Verfahren zur herstellung von isosilybinfreiem silibinin
DE2707675A1 (de) Arzneimittel zur aufloesung bzw. teilweisen aufloesung von gallensteinen
DE2630169A1 (de) Wasserloesliche arzneimittel mit choleretischer wirkung

Legal Events

Date Code Title Description
RPV Change in the person, the name or the address of the representative (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee